Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3142 results found
Expand All
Apply All
3142 results found

Testimony of John F. Crowley President and CEO, BIO House Committee on Energy and Commerce Subcommittee on Health Hearing on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain"
Share
Letters, Testimony & Comments  •  February 11, 2026
Chairman Griffith, Chairman Guthrie, Ranking Member DeGette, Ranking Member Pallone, and distinguished members of the subcommittee, thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), the country’s premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations.Fifty years ago, a small company called Genentech started the biotechnology revolution. What was planned as a 10-minute meeting between an entrepreneur and a biochemist turned into a three-hour gathering that changed the world. These two men, Herb Boyer and Bob Swanson, believed in a new DNA technology that now – five decades later – has saved millions of people worldwide and transformed how we treat patients for some of the most difficult diseases.  Biotechnology has turned death sentences into curable illness. Lives of pain and confinement into those of freedom and joy. And it has brought newfound hope to patients with the promise of happier, healthier times. The industry is filled with people who believe deeply in what we do. Many have personal stories that tie them to this work. They are in this field because they want to improve people’s lives and make the world a better place.  I am one of them. Twenty-five years ago, my two youngest children, Megan and Patrick, were diagnosed with Pompe disease, a rare and fatal neuromuscular disorder. At the time, there was no treatment — no hope beyond comfort care. I left my job, went back to graduate school, and eventually helped start a small biotech company dedicated to developing an enzyme replacement therapy. That therapy — born from the ingenuity and perseverance of American scientists and approved by the FDA — gave my children a chance at life. Today, Megan and Patrick are living full, meaningful lives.  That experience taught me two things I will never forget: first, that access to groundbreaking medical innovation…
Read More

BIO Membership Compact & Social Responsibilities
Share
To be eligible for membership in BIO, a firm or organization must fit into one of the membership categories outlined in BIO’s bylaws (i.e., Core, Associate, Affiliate, and Center members). Further, membership in BIO is open only to firms or organizations that generally support BIO’s public policy positions, and whose own positions and business practices are generally consistent with BIO’s reputation and its policies and principles in support of innovation, including intellectual property rights. As part of the application and membership renewal process, each firm or organization is required to affirm that it meets such criteria.As an indicium of a Core Member’s “support for innovation,” an important criterion includes an assessment of whether a Core Member company invests significantly in innovative (i.e., new and novel) biotechnological research and development (R&D) activities.Beyond these core requirements of membership, BIO expects that its members will not engage in conduct that is detrimental to the purpose or reputation of the organization.BIO Statements and Principles regarding Biotech Social Responsibilities:In addition to BIO’s membership criteria, BIO’s Board of Directors has, over the years, adopted a series of official Statements and Principles that help to set expectations regarding the social responsibilities of our members and the broader biotechnology community, and to encourage societally beneficial conduct. While non-exhaustive, we have provided below the links to some of the most important Statements and Principles adopted by BIO’s Board.Statement of BIO Ethical PrinciplesPrinciples on Protecting Research and Research ParticipantsPrinciples on Responsible Sharing of Truthful and Non-Misleading Information About Medicines With Health Care Professionals and PayersStatement of Ethical Principles for the Care and Use of Animals in Biotechnology ResearchStatement on the Ethical Use of Biotechnology to Promote Public Health and National Security…
Read More

Senior Leadership Team at BIO
Share
Meet the leaders behind the Biotechnology Innovation Organization.
Read More

Reauthorizing the PRV
Share
Policy
prv

Lab Equipment Service Contract Consolidation
Share
BIO Business Solutions - Program
About SU GroupSpecialty Underwriters (SU Group) delivers a customized equipment maintenance solution that streamlines contract management while reducing costs. By consolidating service contracts into one agreement, SU Group provides budget predictability, convenience, and flexibility — ensuring equipment stays covered without the administrative burden of managing multiple vendors.For life sciences companies, SU Group’s coverage spans a wide range of categories, including:General laboratory equipmentMolecular biologyProtein analysisGenomics & proteomicsClinical & R&D lab equipmentCell biology instrumentsImaging & microscopyBiochemical analysisThrough BIO Business Solutions®, member companies receive exclusive discounts and consolidated service solutions, helping them control costs while keeping critical equipment operational.
Read More

D&O and Cyber Insurance
Share
BIO Business Solutions - Program
About AonBIO and Aon have teamed up to introduce comprehensive coverage for Executive Liability and Cyber Insurance programs. Through these programs, BIO members can access and benefit from an expansive coverage of offerings, competitive pricing, and a unique array of defined services all designed to enhance program efficiency and effectiveness through reputed insurance carriers.
Read More

Business Insurance Carrier (P&C, Clinical Trial, Product)
Share
BIO Business Solutions - Program
About ChubbChubb is a global leader in business insurance carrier and has been BIO’s endorsed insurance partner for more than 25 years. With specialized expertise in biotechnology and life sciences, Chubb delivers cost-effective risk management and protection designed for companies advancing innovation at every stage.For life science organizations, Chubb provides comprehensive coverage solutions including property and casualty, product liability, clinical trial liability, errors and omissions, professional liability, and cyber insurance*. Chubb’s team understands the specific risks of the biotech sector and develops tailored solutions to address them.Through BIO Business Solutions®, member companies benefit from exclusive premium credits and specialized support, helping them safeguard operations, maintain compliance, and scale with confidence.*The BIO-Chubb cyber liability insurance offering is for new business only.
Read More

Lab Supplies & Solutions
Share
BIO Business Solutions - Program
About VWR, part of AvantorVWR, part of Avantor is a global leader in life sciences and advanced technologies, delivering laboratory products, production supplies, and services used across pharmaceutical, biotechnology, industrial, education, government, and healthcare organizations.For life science companies, VWR provides reliable access to everything from everyday consumables to complex capital equipment — supporting innovation from early-stage R&D through large-scale manufacturing.Through BIO Business Solutions®, member companies gain access to VWR's national contract, unlocking deep discounts, exclusive rebates, and flexible pricing options designed specifically for the life sciences community. VWR, part of Avantor has been BIO’s preferred partner since 1997, making it one of the longest-running and most impactful programs in the portfolio.
Read More

Inquiry Form for VWR, part of Avantor
Share
BIO Business Solutions
BIO Business Solutions® is the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than half a billion in annual sales, BIO Business Solutions® aggregates the purchasing power of over 4,700 life science companies from North America. Companies of all sizes save substantial money each year through this cost-savings program.To request information for the BIO-VWR Program, please fill the fields below and click the Submit button at the bottom of the form. MktoForms2.loadForm("//app-ab15.marketo.com", "490-EHZ-999", 3825);
Read More

BIO marks wins on PPRV, PBMs
Share
Good Day BIO Newsletter  •  February 9, 2026
BIO celebrates passage of PPRV reauthorization and PBM reform. Also, new legislation would help fight AMR. (943 words, 4 minutes, 42 seconds) Because Feb. 16 is Presidents Day, our next newsletter comes out Tuesday, Feb. 17.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 3
  • 4
  • 5
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO